Log in

Start Your Membership Now

This;OPEN MINDS;Executive Roundtable was delivered on April 24, 2025 by;Tanveer Chaudhry, M.D., Chief Executive Officer of Solace Behavioral Health (Solace). He discussed the evolving role of ketamine and emerging psychedelics in psychiatric care, with a focus on their transformative potential for treatment-resistant conditions. Drawing from his experiences at Solace, this case study covered how these therapies integrate into clinical practice, their outcomes, and the operational challenges involved.

Executive attendees of this session will:

Understand the clinical and operational benefits of ketamine and emerging psychedelics (including psilocybin and MDMA) for psychiatric care.

Identify . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: